Rhythm Pharmaceuticals RYTM
NASDAQ RYTM
$95.71 -2.85 (-2.89%)
At close: Sep 29, 2026 · 4:00 PM EDT

Rhythm Pharmaceuticals (RYTM) Non-Current Debt (2023 - 2026)

Updated

Rhythm Pharmaceuticals' Non-Current Debt came in at $5.5 million for Q3 2025, up 65.0% from $3.33 million a year earlier and up 26.3% from the prior quarter.

Analysis

Rhythm Pharmaceuticals (RYTM) Non-Current Debt (2023 - 2026) Analysis & Trends

Over the trailing twelve months to Sep 30, 2025, Rhythm Pharmaceuticals reported Non-Current Debt of $38.23 million.

  • The five-year range for quarterly Non-Current Debt is $2.98 million (Q2 2024) to $25.05 million (Q1 2025).
  • Year-over-year, Non-Current Debt has increased for three consecutive quarters.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 37.34 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 62.48 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 51.08 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn -
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -108.00 Mn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 51.86 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 23.83 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 60.50 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn -
10 Rhythm Pharmaceuticals 6.78 Bn 5.65 Bn 62.32 Mn 93.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 93.40 Mn
Mar 31, 2026 98.34 Mn
Dec 31, 2025 100.89 Mn
Sep 30, 2025 103.41 Mn
Jun 30, 2025 106.01 Mn
Mar 31, 2025 107.93 Mn
Dec 31, 2024 108.27 Mn
Dec 31, 2023 106.14 Mn
API Access

Rhythm Pharmaceuticals Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=RYTM&period=max&api_key=YOUR_API_KEY